SARAH METZ: Open Payments
NPI 1306505821 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 14 payments from 9 companies in 2025. Trend: 2023 $975 · 2024 $4,332 · 2025 $1,369
Consulting: $720Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $1,117 |
| Legend Biotech USA Inc. | 1 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Novocure Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: RYBREVANT, CARVYKTI, ERLEADA, Nubeqa, Padcev, KISQALI, Optune Gio, KEYTRUDA.
Industry payments across CO — which companies pay providers there.
